Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001493152-25-007954·LCK JNK 1 LLC
Schedule 13G ownership disclosure
Scinai Immunotherapeutics Ltd.
American Depositary Shares, each representing 4,000 Ordinary Shares, no par value · CUSIP: 09073Q203
Event date: 2025-02-09
- Filing-level shares
- 80,757.00
- Percent of class
- 9.5%
- LCK JNK 1 LLC
Shares: 80,757.00 · Class: 9.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-007954
- Form type
- SCHEDULE 13G
- Filer
- LCK JNK 1 LLC
- CIK
- CIK 2055074
- Filed
- Feb 24, 2025
- Reporting period
- Feb 09, 2025
- Description
- Schedule 13G beneficial ownership